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Nutritional muscular dystrophy (NMD), also known as white 
muscle disease or nutritional myodegeneration, is a non-
inflammatory degenerative disease affecting both skeletal 
and cardiac muscles, with animals presenting either in an 
acute or subacute form (Dill and Rebhun 1985; Moore and 
Kohn 1991; Lofstedt 1997). It is most commonly observed 
in regions in which there is selenium (Se)-deficient soil, 
grains and forages (Dill and Rebhun 1985; Lofstedt 1997). 
The clinical presentation includes an acute and rapidly 
progressive syndrome leading to death within hours to 
days, or a subacute form in which muscular weakness is 
the most common presentation (Moore and Kohn 1991; 
Lofstedt 1997). NMD has been reported in cattle, sheep 
and pigs, occurring less frequently in horses, in various 
regions in the United States, Canada, the United Kingdom, 
New Zealand, Australia and Europe (Radostits et al. 1994). 
It has also been reported to affect foals ranging in age 
from neonates to older weanlings (Lofstedt 1997). We 
report a case of diffuse muscular weakness in a four-
day-old foal in which NMD was diagnosed based on the 
clinical presentation and laboratory findings including low 
serum vitamin E and Se concentrations. Although selenium 
toxicity has been reported in horses (as well as cattle and 
sheep) in the Republic of Ireland (Rogers et al. 1990), to 
the authors’ knowledge this is the first report of NMD in a 
foal in the Republic of Ireland. 
caSe DetaIlS
A four-day-old, full-term 45 kg Connemara colt presented 
to University College Dublin (UCD) with a two day history 
of progressive inability to rise unassisted. Gestation 
and parturition were reportedly uneventful, and although 
there was mild flexor contraction of all four limbs, the 
foal could stand and nurse easily on its own. The mare 
was maintained on a grass pasture with no supplements. 
Deworming and vaccination history were unknown and 
there had been no dietary or management changes. The 
mare had one previous healthy foal. At two days’ of age, 
the foal was observed having trouble rising on its own; the 
following day, the foal could not get up without assistance, 
appeared to be weaker and passed tea-coloured urine. The 
foal was referred into UCD the following day.
clINIcal fINDINgS
Upon presentation, the foal was bright, alert and standing. 
When recumbent, it needed assistance to stand, but 
once up, could move around without assistance. The 
foal had normal nursing behaviour and when suckling, 
swallowed normally. All joints and the umbilicus palpated 
within normal limits, and there was moderate flexural 
contraction of all four limbs involving primarily the distal 
interphalangeal joint, with the right front the most severely 
affected. The flexural deformities did not appear severe 
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enough on their own to cause the foal’s inability to rise 
without assistance. The foal was observed to urinate 
frequently in normal quantities with no straining; the urine 
grossly appeared to be normal. The mucous membranes 
were pink and moist with a capillary refill time of less than 
two seconds, and temperature, pulse and respiration were 
all within normal limits. Observing the colt’s hindlimbs 
from the side, they appeared to be in a ‘C’-shaped 
configuration with a downward slope of the pelvis (Figure 
1). The remainder of the physical examination, including 
a neurological examination, was within normal limits. No 
signs of trauma were noted and no ectoparasites were 
found.
Based on the physical and neurological examination, the 
primary problem appeared to be generalised muscular 
weakness. Differentials at this time for muscular 
weakness included systemic illness (sepsis, neonatal 
isoerythrolysis), neuromuscular abnormalities (tick 
paralysis, botulism), musculoskeletal abnormalities 
(myopathies secondary to inflammatory/infectious, 
traumatic, degenerative [inherited, metabolic, 
nutritional] and ischaemic causes, incomplete 
ossification of the cuboidal bones), dysmaturity, 
metabolic/electrolyte derangements (hyperkalaemia, 
hypokalaemia, hypocalcaemia) and endocrine disorders 
(hypoadrenocorticism, hypothyroidism). Although the 
foal appeared to be weak rather than ataxic, congenital 
disorders of the vertebrae/spinal cord and trauma to the 
vertebrae/spinal cord including the pelvis could not be 
ruled out.
Blood was submitted for a complete blood count (CBC) 
including fibrinogen, serum biochemistry, venous blood 
gas, immunoglobulin G (IgG) concentrations and aerobic 
and anaerobic bacterial culture. Radiographs taken of 
the hocks and carpi revealed normal ossification, while 
radiographs of the distal limbs showed no congenital 
abnormalities which might explain the presence of 
the flexural deformities. Radiographs taken of the 
lumbosacral spine revealed no evidence of trauma. 
The IgG concentration was 400 mg/dl (4 g/l) (reference 
range > 800 mg/dl [> 8 g/l]) indicating partial failure 
of passive transfer. The blood culture yielded no growth 
after one week of incubation. The CBC was unremarkable, 
while the serum biochemistry revealed a profound 
hyponatraemia (118 mmol/l; reference range 132-
146 mmol/l), hyperkalaemia (4.52 mmol/l; reference 
range 2.7-3.5 mmol/l) and hypochloraemia (85 mmol/l; 
reference range 98-104 mmol/l), and a severely elevated 
Figure 1: A four-day-old full-term Connemara colt that presented to University College Dublin with a two-day history of progressive inability to rise unassisted. Note the 
moderate flexural contraction of all four limbs involving primarily the distal interphalangeal joint and the ‘C’-shaped configuration of the hindlimbs and downward slope 
of the pelvis.
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creatinine phosphokinase ([CPK] 2450 iu/l; reference 
range < 70 iu/l) and aspartate aminotransferase ([AST] 
4970 iu/l; reference range 101-154 iu/l); the blood 
urea nitrogen (BUN) and creatinine concentrations were 
within normal limits. The main differentials for foals with 
hyponatraemia, hyperkalaemia and hypochloraemia include 
uroperitoneum due to rupture of part of the urinary tract 
(most commonly bladder), renal disease and muscle 
degeneration (rhabdomyolysis). Adrenal insufficiencies, as 
well as gastrointestinal (GI) diseases such as enterocolitis 
were also considered, but given both the lack of historical 
evidence and clinical signs, GI diseases were considered 
unlikely to be involved. The main differential for elevations 
in serum CPK and AST is a myopathy (inflammatory/
infectious [sepsis, clostridial myositis], traumatic, 
degenerative [inherited, metabolic, nutritional], ischaemic). 
Causes of inherited myopathies include polysaccharide 
storage myopathy and glycogen branching enzyme 
deficiency while nutritional causes include NMD.
Ultrasonography of the abdomen including both kidneys 
demonstrated an intact bladder with no free fluid. A free-
catch urine sample was examined revealing a specific 
gravity of 1.006, with no evidence of blood. Renal 
disease was considered unlikely since there was no 
evidence of azotaemia, and the low urine specific gravity 
was considered to be normal in a nursing foal. Although 
neonates can adequately concentrate their urine, they 
typically have very dilute urine (1.001-1.006) due to their 
almost completely liquid (i.e., milk) diet. Based on the 
above findings and the elevated serum muscle enzymes, 
rhabdomyolysis was considered to be the cause of the 
electrolyte disturbances, although adrenal insufficiency 
could not be completely ruled-out. Based on the 
signalment, clinical, laboratory and radiographic findings 
infectious, traumatic, inherited and ischaemic causes of 
myopathy in this foal were all considered unlikely with the 
primary differential being NMD.
treatMeNt
An intravenous jugular catheter was placed and treatment 
initiated including 0.9% sodium chloride and 5% 
dextrose (2.2 ml/kg/hr, IV), ceftiofur HCl (Excenel, Pfizer 
Animal Health) (2.2 mg/kg, IV, q 12 h) and omeprazole 
(Gastroguard, Merial )(4 mg/kg, PO, q 24 h). A dextrose-
containing solution was chosen in an attempt to reduce 
serum potassium concentrations by driving potassium into 
the cells. Despite evidence of partial failure of passive 
transfer, the owner declined treatment with intravenous 
plasma based on financial costs, the lack of evidence 
of sepsis and that fact that the foal was on systemic 
antibiotics. The foal was assisted to stand every two hours 
and nursing, urination and defecation were monitored.
The following day, the foal was stronger, but still could not 
rise unassisted. A repeat CBC and serum biochemistry 
revealed the foal still to be hyponatraemic (123 mmol/l), 
hyperkalaemic (4.33 mmol/l) and hypochloraemic (88 
mmol/l) with elevated serum muscle enzymes (CPK 648 
iu/l; AST 3485 iu/l). Results from urine collected prior 
to fluid therapy and submitted for sediment analysis and 
fractional excretion of electrolytes were within normal 
limits. A repeat venous blood gas revealed a mild 
metabolic acidosis (pH 7.3, reference range 7.35-7.45; 
HCO3
- 20.8 mEq/l, reference range 22-26 mEq/l), possibly 
due to lactic acid release from muscle and alterations in 
strong ions (i.e., hyponatraemic acidosis). 
To investigate for nutritional causes (i.e., NMD), blood 
was submitted from the mare and foal for measurement 
of vitamin E (two samples taken at different times of the 
day), Se and glutathione peroxidase (GPx). The owner 
declined a muscle biopsy due to financial restrictions. 
Baseline cortisol was also measured from blood samples 
taken at two different times to assess the adrenal 
function. The foal was then treated with a vitamin E-Se 
combination (Vitesel, Norbrook Laboratories Limited) (2.5 
mg Se [2.5 mg/45 kg], IM, once, divided into two deep 
injections given in the semimembranosus muscles). As 
the foal was tolerating the fluid load, intravenous fluid 
therapy was continued at the same rate but changed to 
a solution containing a total of 234 mEq/L of sodium 
with bicarbonate and dextrose (NaHCO3, 90 mEq added 
to 10% dextrose in 0.9% saline, 1 L) to help drive 
potassium intracellularly. Carprofen (Rimadyl, Pfizer Health 
Corp) (0.7 mg/kg, IV, once) was also given to address 
any inflammation and pain associated with muscle 
degeneration and with the flexural contractions. The foal 
also received physical therapy on the contracted tendons 
two to three times per day.
By the third day the foal was brighter, able to get up 
unassisted, moved around the stall more freely and 
appeared less contracted with less sloping of the pelvis. 
A repeat venous blood gas, CBC and serum biochemistry 
including the sodium (135 mmol/l), potassium (3.86 
mmol/l) and chloride (97 mmol/l) concentrations were 
all within normal limits. The serum CPK (493 iu/l) and 
AST (1340 iu/l) concentrations had both decreased 
significantly, indicating both resolution and lack of ongoing 
muscle damage. The foal’s cortisol concentrations were 
within normal limits, while the GPx (10.1 u/ml PCV; 
reference range 30-150 u/ml PCV), blood Se (0.5 µmol/l; 
reference range 0.75-3.0 µmol/l) and serum vitamin E 
(2.1 µmol/l from first sample, 1.4 µmol/l from the second 
sample; reference range 3.0-20.0 µmol/l) concentrations 
were all low, supporting the diagnosis of NMD; the mare’s 
GPx (38 u/ml PCV), blood Se (1.94 µmol/l) and serum 
vitamin E (5 µmol/l) concentrations were all within normal 
limits. Based on the normal electrolyte concentrations 
and decreasing muscle enzymes, intravenous fluids 
were discontinued. The following day, the foal remained 
bright and alert and able to get up on its own, with all 
serum electrolyte concentrations within normal limits. 
and both the serum CPK (280 iu/l) and AST (1026 
iu/l) concentrations further decreased. The foal was 
administered a second treatment of vitamin E-Se (2.5 mg 
Se, IM, once) and carprofen (0.7 mg/kg, IV, once) and 
discharged on the sixth day of hospitalisation. In order 
to minimise muscle damage secondary to exertion, and 














to allow for continued muscle healing, it was instructed 
to keep the mare and foal stall-restricted for at least one 
week, followed by turn-out into a small paddock. It was 
recommended to treat the foal with vitamin E-Se at 10 
days and six to eight weeks of age and also to supplement 
the animal with oral vitamin E since the intramuscular 
formulation contains very little. 
Although the mare’s GPx, blood Se and serum vitamin 
E concentrations were all within normal limits, it was 
suspected that the mare had been deficient at one 
point during gestation since a foal’s vitamin E and Se 
status are directly affected by the mare’s status. Thus, 
it was recommended that vitamin E and Se be measured 
for the rest of the herd, especially for any remaining 
pregnant mares, and to supplement any of the deficient 
pregnant mares prior to parturition along with treating 
their foals with vitamin E-Se when born, and again at two 
and six weeks of age. Since Se toxicity can occur, it was 
recommended that the dose of Se not exceed 200 µg/kg 
in foals. 
Fifteen months following discharge the colt was reported 
doing well, with no problems with the remainder of the 
herd.
DIScuSSION
NMD is a non-inflammatory degenerative disease 
affecting both skeletal and cardiac muscles, with animals 
presenting either in an acute or subacute form (Dill and 
Rebhun 1985; Moore and Kohn 1991; Lofstedt 1997). 
Although Se toxicity has been reported in horses (as well 
as cattle and sheep) in the Republic of Ireland and Se 
deficiency has been reported to be widespread in cattle 
and sheep in most of the counties in the Republic of 
Ireland (Rogers et al. 1990), to the authors’ knowledge 
this is the first report of NMD in a horse in the Republic 
of Ireland. The disease occurs in regions with Se-deficient 
soils, resulting in the production of Se-deficient grains and 
forages (Dill and Rebhun 1985; Moore and Kohn 1991; 
Lofstedt 1997). In the equine and other species, NMD is 
also associated with vitamin E deficiency (Lofstedt 1997). 
Vitamin E and Se act synergistically to prevent peroxidative 
damage of lipid-containing membranes, with vitamin E 
inactivating oxygen-free radicals while Se is a component 
of the enzyme glutathione peroxidase which acts to destroy 
already formed oxygen-free radicals (Burk and Hill 1993; 
Lofstedt 1997).
Typically, foals with subacute NMD are bright and alert 
with profound muscular weakness as seen with the foal 
described here (Dill and Rebhun 1985; Moore and Kahn 
1991; Lofstedt 1997). Foals that have myocardial, as well 
as skeletal muscle degeneration, may present with an 
arrhythmia, tachycardia and profound weakness that may 
result in sudden death (Dill and Rebhun 1985). In addition 
to general muscular weakness, animals may present 
with dysphagia resulting in secondary complications such 
as aspiration pneumonia and failure of passive transfer 
(Dill and Rebhun 1985; Moore and Kahn 1991). The foal 
described here did have partial failure of passive transfer, 
but did not have clinical evidence of dysphagia nor 
aspiration pneumonia, although endoscopy and thoracic 
radiographs were not performed. Full and partial failure 
of passive transfer may occur due to inadequate colostral 
immunoglobulin concentration (decreased production, 
premature lactation), inadequate colostral intake (failure to 
suckle, dysphagia) and poor gut absorption. Although the 
foal had been observed by the owners to stand and nurse 
normally following parturition, it is possible that the foal 
did not take in adequate amounts of colostrum before gut 
closure due to an inability to rise and nurse as frequently 
as a normal foal would. Interestingly, it has been 
demonstrated that mares supplemented with a synthetic 
form of vitamin E resulted in an increased passive transfer 
of immunoglobulins to foals, likely as a result of increased 
concentrations of immunoglobulins in their colostrum 
(Hoffman et al. 1999; Hargreaves 2002). Therefore, mares 
with low vitamin E may have decreased concentrations of 
colostral immunoglobulins contributing to failure of passive 
transfer to the foal. 
The diagnosis of NMD is based on a combination of 
typical clinical signs, elevated muscle enzymes, decreased 
blood Se and/or GPx activity and response to treatment 
with vitamin E-Se (Dill and Rebhun 1985; Moore and 
Kohn 1991). Muscle biopsies may be useful in defining 
characteristic histological lesions such as hyaline 
degeneration, lysis and fragmentation of muscle fibres 
(Lofstedt 1997), although alone they are not diagnostic. 
Serum CK and AST values are typically elevated in foals 
with NMD (Gill and Rebhun 1985; Moore and Kohn 1991; 
Lofstedt 1997; Perkins et al. 1998), as found in the 
current case. CK is the most muscle-specific enzyme 
and indicates active muscle damage as it increases 
quickly (four to six hours) following muscle damage and 
has a relatively short half-life (six hours), returning to 
normal within 48 hours after muscle damage has stopped 
(Duncan and Prasse 2003). In most foals, recumbency 
will not result in CK activity greater than 1000 u/L, while 
CK activity greater than 5000 u/L typically indicates 
myodegeneration (Lofstedt 1997). Although not performed 
in the present case due to financial restrictions, serum 
cardiac muscle isoenzymes (CK, LDH) and serum troponin 
I can be measured to evaluate for myocardial damage.
Rhabdomyolysis often contributes to the development 
of hyponatraemia, hyperkalaemia and hypochloraemia. 
As the musculature makes up approximately 55% of the 
total body mass (Dill and Rebhun 1985) and is a major 
intracellular reservoir for potassium and phosphorus, 
disruption of the muscle cell wall allows a large efflux 
of these intracellular electrolytes and an influx of water, 
sodium and chloride into the muscle tissue resulting in the 
above described electrolyte disturbances (Better 1990; 
Perkins et al. 1998). These electrolyte changes typically 
coincide with the onset of clinical signs and increase in 
CK activity in foals with acute rhabdomyolysis (Perkins 
et al. 1998). However, because of the development of 
myoglobinuria as a result of muscle breakdown, foals with 
acute rhabdomyolysis may develop secondary acute renal 
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failure as a result of pigment nephropathy. Thus, foals with 
acute rhabdomyolysis need to have their renal function 
closely investigated and monitored during the duration of 
the disease process.
The activity of GPx, a Se-containing enzyme, strongly 
correlates with blood Se concentrations (Roneus 1982), 
since Se is incorporated into red blood cells (RBC) as GPx 
during erythropoiesis (Rotruck et al. 1973). Thus, GPx 
activity is a good indicator of the animal’s Se status weeks 
to months prior to the sample collection (Lee et al. 1995) 
while blood Se concentrations assess the animal’s current 
Se status (Moore and Kohn 1991; Lofstedt 1997). Foals 
deficient in Se, such as the foal described in this report, 
will have low GPx activity when RBCs that had matured in 
a period of adequate Se are replaced with RBCs that had 
matured during a period of Se deficiency (Moore and Kohn 
1991). However, neither a decreased blood Se nor GPx 
activity alone is sufficient for the diagnosis of NMD, since 
animals raised in Se-deficient areas with no clinical signs 
of NMD may have decreased blood Se and/or GPx activity 
(Roneus 1982; Dill and Rebhun 1985; Moore and Kohn 
1991; Lee et al. 1995). 
The main treatments for foals with NMD include 
intramuscular injections of vitamin E and Se products, 
exercise restriction and supportive care (Dill and Rebhun 
1985; Moore and Kohn 1991; Lofstedt 1997). Since 
the injections can cause transient muscle pain, it is 
recommended to divide the dose and give into deep 
muscles at two separate sites (Dill and Rebhun 1985; 
Maas et al. 1996). The amount of vitamin E in currently 
available combined vitamin E-Se products is minimal, 
so if NMD is believed to be due to vitamin E deficiency, 
then supplementation with additional vitamin E is 
recommended. Interestingly, although there appears to 
be a joint role for vitamin E and Se in the prevention of 
NMD, Se given alone has been shown to be effective 
in treating and preventing the disease (Dill and Rebhun 
1985). Mildly affected foals, such as in this report, 
improve rapidly following Se injections even though there is 
a significant delay before improvements in GPx activity can 
be documented (Maas et al. 1996). Since acute Se toxicity 
can occur, it is recommended not exceed 200 µg/kg in 
foals (Traub-Dargatz et al. 1986). Clinical signs of acute 
toxicity include depression, ataxia, muscle weakness, 
blindness, diarrhoea, dyspnoea and a garlic odour to the 
breath (Seawright et al. 1983; Dill and Rebhun 1985; 
Traub-Dargatz et al. 1986; Sharman 2007). 
Hyperkalaemia may be the most life-threatening electrolyte 
abnormality in foals with NMD due to the possibility of 
cardiac arrhythmias. Typical treatments for hyperkalaemia 
include the use of glucose, sodium bicarbonate and insulin 
in an attempt to drive potassium from the extracellular to 
the intracellular fluid compartments (Kokko 1996). With 
the current foal, we chose to initially use glucose in a 
potassium-free fluid, followed by the addition of sodium 
bicarbonate. This was eventually successful, likely because 
the muscle damage was only moderate which resulted 
in the maintenance of enough intact muscle cells into 
which potassium could be driven (Perkins et al. 1998). 
Interestingly, foals with severe rhabdomyolysis often do 
not respond to the typical treatments aimed at driving 
potassium intracellularly, as a result of the severity of the 
muscle damage and major loss of the intracellular fluid 
compartments (Perkins et al. 1998). Thus, in the face 
of severe muscle damage it has been hypothesized that 
it may be more efficacious to direct treatment towards 
enhanced potassium excretion through the renal or GI 
system (Perkins et al. 1998). Mineralocorticoids, which 
act on the renal distal tubules and collecting ducts, and/
or diuretics such as furosemide can be used to increase 
renal potassium loss (Ganon 1989; deMorais et al. 1995; 
Perkins et al. 1998) while polystyrene sulfate, a cation 
exchange resin, increases faecal potassium loss when 
given orally or rectally (deMorais et al. 1995; Koko 1996; 
Perkins et al. 1998).
If dysphagic, it is recommended to muzzle the foal and 
support it nutritionally using a nasogastric tube in order 
to prevent aspiration pneumonia. Because the foal in 
the present report did not exhibit any clinical signs of 
dysphagia, it was decided to allow the foal to continue to 
nurse from the mare. Interestingly, a previous report found 
that three out of four foals diagnosed with NMD developed 
clinical evidence of bronchopneumonia despite nasogastric 
feeding (Perkins et al. 1998) while another report found 
that 24% of foals with NMD had a post-mortem diagnosis 
of aspiration pneumonia (Moore & Kohn 1991). It is 
therefore recommended to maintain foals with NMD on 
broad-spectrum antibiotics, such as a third generation 
cephalosporin used in the current case, whether or not 
the foal is maintained with nasogastric feeding (Moore and 
Kohn 1991; Perkins et al. 1998).
Because equine neonates should gain 0.5-1 kg per day, 
the foal was weighed before and every day following the 
initiation of drug and fluid therapy so as to adjust doses 
accordingly, and to monitor hydration and adequate 
caloric intake. Interestingly, large weight gains have been 
reported in foals 24 hours following the onset of acute 
rhabdomyolysis (Perkins et al. 1998), with the mechanism 
hypothesised to be a combination of activation of the 
renin-angiotensin system and aldosterone release in 
response to hyperkalaemia and a large shift of water into 
damaged muscle (Better 1990; Perkins et al. 1998). This 
was not noted in the present case, likely because the 
degree of muscle damage and hyperkalaemia were only 
moderate.
The prognosis for foals with NMD is guarded, but 
decreasing CK activity found with serial sampling, such 
as in the current case, has been associated with a good 
prognosis (Moore and Kohn 1991). Poor prognostic 
indicators include clinical signs associated with the acute 
form of the disease, the inability of the foal to support its 
own body weight, severe myoglobinuria and cardiac muscle 
involvement (Dill and Rebhun 1985). The acute form of 
the disease has a much poorer prognosis for survival than 
the subacute form, with mortality rates of up to 95% while 
mortality rates for the subacute disease range between 
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30-45% (Combs and Combs 1986).
The last trimester of pregnancy is the most important 
time to monitor the vitamin E-Se status of the mare 
and to supplement if needed (Moore and Kohn 1991). 
Supplementing the mares in the prepartum period is 
an extremely efficient way to protect the foals from 
Se deficiency, since the neonates’ Se status depends 
largely on the status of the mare during pregnancy (Maas 
et al. 1996). When supplementing the mare with Se 
during gestation, various recommendations have been 
made including 1 mg/horse/day (Maylin et al. 1980), 
4.4 mg/horse/week (Maylin et al. 1980) or 6 mg/
horse/week (Bergsten et al. 1970). Treating foals at 
birth prophylactically with intramuscular Se does not 
prevent NMD acquired in utero (Lofstedt 1997), but is 
recommended in foals from un-supplemented mares in 
vitamin E-Se deficient regions whose vitamin E-Se status 
is unknown. Recommended protocols include 2.5 mg 
Se/45 kg once, repeated two and six weeks later (Dill 
and Rebhun 1985). The Se status of the soil, forage and 
grain should also be investigated. It has been reported 
that forage, grain and soil Se levels of <0.1 ppm suggest 
deficiency (Dill and Rebhun 1985).
In conclusion, NMD should be included as a differential 
in any foal that presents with generalised muscular 
weakness. Confirmation of the disease is made based 
on the typical clinical signs, elevations in CK and 
AST, evaluation of whole blood Se, vitamin E and GPx 
activity and rapid response to vitamin E-Se therapy. 
Herd surveillance programs with Se supplementation as 
required are the best ways to minimise the incidence of 
the disease.
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